Vasileios Skaramagkas, Iro Boura, Georgios Karamanis, Ioannis Kyprakis, Dimitrios I. Fotiadis, Zinovia Kefalopoulou, Cleanthe Spanaki, Manolis Tsiknakis
{"title":"Dual stream transformer for medication state classification in Parkinson’s disease patients using facial videos","authors":"Vasileios Skaramagkas, Iro Boura, Georgios Karamanis, Ioannis Kyprakis, Dimitrios I. Fotiadis, Zinovia Kefalopoulou, Cleanthe Spanaki, Manolis Tsiknakis","doi":"10.1038/s41746-025-01630-1","DOIUrl":null,"url":null,"abstract":"<p>Hypomimia is a prominent, levodopa-responsive symptom in Parkinson’s disease (PD). In our study, we aimed to distinguish ON and OFF dopaminergic medication state in a cohort of PD patients, analyzing their facial videos with a unique, interpretable Dual Stream Transformer model. Our approach integrated two streams of data: facial frame features and optical flow, processed through a transformer-based architecture. Various configurations of embedding dimensions, dense layer sizes, and attention heads were examined to enhance model performance. The final model, trained on 183 PD patients, attained an accuracy of 86% in differentiating between ON- and OFF-medication state. Moreover, uniform classification performance (up to 88%) was obtained across various stages of PD severity, as expressed by the Hoehn and Yahr (H&Y) scale. These values highlight the potential of our model as a non-invasive, cost-effective instrument for clinicians to remotely and accurately detect patients’ response to treatment from early to more advanced PD stages.</p>","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":"16 1","pages":""},"PeriodicalIF":12.4000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41746-025-01630-1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Hypomimia is a prominent, levodopa-responsive symptom in Parkinson’s disease (PD). In our study, we aimed to distinguish ON and OFF dopaminergic medication state in a cohort of PD patients, analyzing their facial videos with a unique, interpretable Dual Stream Transformer model. Our approach integrated two streams of data: facial frame features and optical flow, processed through a transformer-based architecture. Various configurations of embedding dimensions, dense layer sizes, and attention heads were examined to enhance model performance. The final model, trained on 183 PD patients, attained an accuracy of 86% in differentiating between ON- and OFF-medication state. Moreover, uniform classification performance (up to 88%) was obtained across various stages of PD severity, as expressed by the Hoehn and Yahr (H&Y) scale. These values highlight the potential of our model as a non-invasive, cost-effective instrument for clinicians to remotely and accurately detect patients’ response to treatment from early to more advanced PD stages.
低血症是帕金森病(PD)中一种显著的左旋多巴反应性症状。在我们的研究中,我们旨在区分PD患者的多巴胺能药物状态,使用独特的,可解释的双流转换器模型分析他们的面部视频。我们的方法集成了两种数据流:面部框架特征和光流,通过基于变压器的架构进行处理。研究了不同的嵌入维度、密集层大小和注意头的配置,以提高模型的性能。最终的模型在183名PD患者身上进行了训练,在区分开和关药物状态方面达到了86%的准确率。此外,根据Hoehn and Yahr (H&;Y)量表,在PD严重程度的各个阶段获得了统一的分类表现(高达88%)。这些价值突出了我们的模型作为一种非侵入性、成本效益高的工具的潜力,临床医生可以远程准确地检测患者对早期到晚期PD治疗的反应。
期刊介绍:
npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics.
The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.